Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longeveron Inc (NQ: LGVN ) 3.900 +0.380 (+10.80%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Longeveron Inc < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Why Is U Power (UCAR) Stock Up 69% Today? April 08, 2024 U Power stock is heading higher on Monday with heavy trading of UCAR as investors celebrate plans for a battery swap service. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session April 08, 2024 Via Benzinga Why Is Longeveron (LGVN) Stock Up 82% Today? April 08, 2024 Longeveron stock is up on Monday after the company announced plans for a proposed public offering of LGVN shares and warrants. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 08, 2024 It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket April 08, 2024 Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of... Via Benzinga Recap: Longeveron Q4 Earnings February 27, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session April 05, 2024 Via Benzinga Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update March 28, 2024 Via Investor Brand Network Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket March 28, 2024 Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. Via Benzinga Researchers Link Type 2 Diabetes to Heightened Alzheimer’s Risk March 27, 2024 Via Investor Brand Network Earnings Scheduled For February 27, 2024 February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. Via Benzinga Earnings Preview For Longeveron February 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 20, 2024 Via Benzinga BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split March 20, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Tuesday's After-Market Session March 19, 2024 Via Benzinga Study Links Parkinson’s Onset in Rocky Mountain Area to Agricultural Pesticides March 01, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Reports on Year-End 2023 Financial Results, Corporate Update February 28, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces Plans to Release Year-End 2023 Financial Results, Corporate Update February 22, 2024 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc.’s (NASDAQ: LGVN) ELPIS Trial Demonstrates Potential Survival Benefit of Lomecel-B(TM) for HLHS Patients February 21, 2024 Via Investor Brand Network Study Links Ramadan Fasting to Lower Risk of Chronic Disease Development February 14, 2024 Via Investor Brand Network BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting February 13, 2024 BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and... Via Benzinga Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech’s Investigational Alzheimer’s Treatment Shows Positive Trial Results February 08, 2024 --News Direct-- Via News Direct Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech's Investigational Alzheimer's Treatment Shows Positive Trial Results February 07, 2024 Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotech company aiming to slow the effects of life-threatening and chronic aging-related conditions using cellular therapies, is making inroads with... Via Benzinga Longeveron Inc.’s (NASDAQ: LGVN) Long-Term Follow-Up Data from Its ELPIS I Clinical Trial Presented at the 2023 Annual Scientific Sessions of the American Heart Association February 07, 2024 Via Investor Brand Network BioMedNewsBreaks – H.C. Wainwright & Co. Reiterates ‘Buy’ Rating, $6 PT on Longeveron (NASDAQ: LGVN) February 06, 2024 Via Investor Brand Network Topics Intellectual Property Exposures COVID-19 Intellectual Property Dietician Tips for Boosting Muscle Mass, Living Longer January 31, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 30, 2024 Via Benzinga BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Granted US Patent Allowance for Key Technology Behind Lead Investigation Product January 29, 2024 Via Investor Brand Network Topics Intellectual Property Exposures COVID-19 Intellectual Property 12 Health Care Stocks Moving In Monday's Pre-Market Session January 29, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.